Navigation Links
Pfizer to Acquire FoldRx Pharmaceuticals
Date:9/1/2010

ATTR-PN," said Geno Germano, president and general manager, Pfizer Specialty Care Business Unit.  "This transaction will add another important component to the growing portfolio of innovative in-line and investigational medicines for orphan and rare diseases within Pfizer's Specialty Care Business, and will complement the current and planned future research and clinical development taking place in Pfizer's Specialty Care Neuroscience disease area," continued Mr. Germano.

"Over the past five years the FoldRx team has successfully developed tafamidis from the bench stage to MAA submission," said Richard Labaudiniere, Ph.D., president and chief executive officer of FoldRx.  "Pfizer's strong clinical and regulatory resources, global marketing reach, and commitment to the treatment of rare diseases will significantly enhance the ability to pursue the goal of efficiently bringing tafamidis to all patients affected by this devastating neurodegenerative disease."

FoldRx has employed its proprietary yeast-based drug target discovery platform to build its portfolio of preclinical and clinical candidates.  Its screening engine is rapid and efficient in evaluating potential treatment candidates in a wide range of diseases caused by misfolded proteins.  Using this screening engine, FoldRx is also actively engaged in an innovative early drug discovery program to identify therapeutic agents for cystic fibrosis, Parkinson's disease and Huntington's disease.  

While specific financial terms were not disclosed, Pfizer will make an upfront payment and contingent payments if certain milestones are achieved.  The closing of the transaction is subject to regulatory approval in the United States and is expected to occur later this year.  

Pfizer's financial advisor for the transaction was Jefferies & Company, Inc., while Ropes & Gray LLP was its legal advisor.  Goldman Sachs & Co. served as FoldRx's financia
'/>"/>

SOURCE Pfizer Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Wyeths Torisel and Roche/Genentechs Avastin Will Challenge Pfizers Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma
2. Kosans Motilin Receptor Agonist, Licensed to Pfizer, Enters Phase 1 Clinical Trial in Gastroesophageal Reflux Disease
3. Coley Pharmaceutical Group and Pfizer Nominate Additional Anti-Cancer Compound for Clinical Development
4. Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer
5. NicOx Announces Pfizer Initiates Phase 2 Clinical Development for PF-03187207 in Japan
6. Tacere Therapeutics Enters Collaboration and License Agreement With Pfizer To Develop and Commercialize RNAi Hepatitis C Drug
7. MannKind Addresses Pfizers Announcement Regarding Exubera
8. Quark Pharmaceuticals Announces First Patient Dosing by Pfizer in Phase II Trial of RNAi Therapy in Diabetic Macular Edema
9. Silence Therapeutics to Receive $1.9m Milestone Payment as Pfizer and Quark Commence Phase II Trial
10. Medarex Receives Milestone Payment from Pfizer for Investigational New Drug Application Filing
11. Pfizer Contributes Critical Data to URMC Drug Safety Initiative
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... Calif. , Nov. 24, 2014  Rigel Pharmaceuticals, Inc. ... Gower is retiring from the board of directors and ... Raul Rodriguez , most recently serving as the company,s ... chief executive officer and join the board of directors.  ... since 2005, will become chairman. Mr. Gower is expected to ...
(Date:11/24/2014)...  Pifflers United Chronic and Invisible Illnesses Support ... results of a study of ActiPatch®, a new ... fibromyalgia pain. The results demonstrated that when used ... clinically meaningful pain reduction can be achieved. ... used ActiPatch® for 7 days and were then ...
(Date:11/23/2014)... 23, 2014 Anthera Pharmaceuticals, Inc. (Nasdaq: ... Truex , President and Chief Executive Officer, will present ... Healthcare Conference. Anthera will present at ... Hotel in New York City . ... Pharmaceuticals is a biopharmaceutical company focused on developing and ...
Breaking Medicine Technology:Rigel Announces Executive Management Changes 2Rigel Announces Executive Management Changes 3Pifflers United - "Supporting Anyone Living With Chronic/Invisible Illness" Reports ActiPatch Bioelectronic Therapy Relieves Chronic Pain In Fibromyalgia 2Pifflers United - "Supporting Anyone Living With Chronic/Invisible Illness" Reports ActiPatch Bioelectronic Therapy Relieves Chronic Pain In Fibromyalgia 3Anthera Pharmaceuticals to Present at Annual Piper Jaffray Healthcare Conference 2
(Date:11/26/2014)... For its December issue , Atlantic ... on Blue Cross and Blue Shield Plans* interviewed officials ... strategies the two Blues plans are implementing in order ... sleep apnea, ranging from brick-and-mortar retail stores to patient ... increased rates of a variety of serious disorders, including ...
(Date:11/26/2014)... Howell, NJ (PRWEB) November 26, 2014 ... issues,” and Florida-based SeniorNet, a nonprofit organization providing the ... have teamed up to help seniors navigate the rough ... will focus on educating seniors on the topic of ... through the somewhat complicated process of applying for this ...
(Date:11/26/2014)... Angeles, California (PRWEB) November 26, 2014 ... score of 3.9 out of 5. This score represents ... over the three years to 2014 as a result ... for medical suction machines, which are largely considered nondiscretionary. ... the purchasing process, buyers have some degree of flexibility, ...
(Date:11/26/2014)... Sonoran Vein and Endovascular nurse, ... Distinguished Preceptorship Award from The American Association ... the advancement of nurse practitioners. The Distinguished Preceptorship ... had made a significant contribution toward increasing the ... of Nurse Practitioners (AANP) is the largest full-service ...
(Date:11/26/2014)... 25, 2014 (HealthDay News) -- The number of emergency department ... in 2010 to a record 136 million in 2011, according ... The findings also showed that fewer people were going to ... identified as needing medical care within two hours of arriving ... according to the research. Sixty percent of patients arrived ...
Breaking Medicine News(10 mins):Health News:AIS Newsletter Reports on Strategies Blues Plans Are Implementing to Combat Sleep Apnea 2Health News:AIS Newsletter Reports on Strategies Blues Plans Are Implementing to Combat Sleep Apnea 3Health News:Senior Planning Services Teams Up with SeniorNet To Educate Seniors On Medicaid Planning 2Health News:Medical Suction & Vacuum Products Procurement Category Market Research Report from IBISWorld has Been Updated 2Health News:Medical Suction & Vacuum Products Procurement Category Market Research Report from IBISWorld has Been Updated 3Health News:Medical Suction & Vacuum Products Procurement Category Market Research Report from IBISWorld has Been Updated 4Health News:Sonoran Nurse Receives Distinguished Preceptorship Award from The American Association of Nurse Practitioners 2Health News:ER Visits on the Rise, Study Reports 2
... , Susan Torroella , COO, MEDEX Global Group, ... Jan. 20 An ambitious leadership agenda and commitment ... worldwide have propelled the HBA to over 5,200 members across 14 ... president Susan Torroella , and the new 2010 Board of ...
... , CHICAGO , Jan. ... January/February issue of the American Journal of Health Promotion ... members who participated in fitness-related activities within an incentive-based health ... study examined the medical claims data over one year of ...
... , , Conference will confront Health Disparities ... , WASHINGTON , Jan. 20 The National ... Health Disparities, March 4-6, 2010 at the Barbara Jordan ... The conference will provide journalists the tools to effectively report on ...
... WEDNESDAY, Jan. 20 (HealthDay News) -- A new national ... of complementary and alternative medicine could help Western doctors ... medicine, or CAM, includes such therapies as acupuncture, yoga, ... prevalence of CAM use today, most physicians still know ...
... use of ,smart, phones, computers soars , WEDNESDAY, Jan. 20 (HealthDay ... watching TV, playing video games or surfing the Internet has increased ... , In fact, over the past five years the amount of ... by 1 hour, 17 minutes a day -- from 6 ...
... ... substantiated by accurate data analysis and reporting, four colleges within the Community College ... ... January 20, 2010 -- In today’s technology-driven environment, where sound business decisions are ...
Cached Medicine News:Health News:Healthcare Businesswomen's Association Announces 2010 Board of Directors 2Health News:Healthcare Businesswomen's Association Announces 2010 Board of Directors 3Health News:Healthcare Businesswomen's Association Announces 2010 Board of Directors 4Health News:Research Indicates Participants in Incentive-Based Health Promotion Programs Have Lower Healthcare Costs 2Health News:Research Indicates Participants in Incentive-Based Health Promotion Programs Have Lower Healthcare Costs 3Health News:Research Indicates Participants in Incentive-Based Health Promotion Programs Have Lower Healthcare Costs 4Health News:Black Journalists' Group to Hold Conference on African-American Health and Health Care Disparities 2Health News:Black Journalists' Group to Hold Conference on African-American Health and Health Care Disparities 3Health News:U.S. Kids Using Media Almost 8 Hours a Day 2Health News:U.S. Kids Using Media Almost 8 Hours a Day 3Health News:U.S. Kids Using Media Almost 8 Hours a Day 4Health News:U.S. Kids Using Media Almost 8 Hours a Day 5Health News:New Hampshire Community Colleges Choose Rapid Insight for Data Reporting Needs 2
The Lang Stereotest was created to simplify stereopsis screening in children. It is based on two principles: random dots and cylindrical gratings. The Lang Stereotest I measures disparities: Star 600...
8 X 1 Red Filter. Color Filters are designed to filter out all other color regions of the visible spectrum except the specified color. Color Filters are excellent for contrast enhancement and color r...
Maxi-Lite diagnostic penlight features a twist-on backswitch....
Features a twist-on backswitch with a diffused, cobalt blue, light beam. Packaged with fluorescein strips....
Medicine Products: